Your browser doesn't support javascript.
loading
Raloxifene hydrochloride is an adjuvant antiviral treatment of postmenopausal women with chronic hepatitis C: a randomized trial.
Furusyo, Norihiro; Ogawa, Eiichi; Sudoh, Masayuki; Murata, Masayuki; Ihara, Takeshi; Hayashi, Takeo; Ikezaki, Hiroaki; Hiramine, Satoshi; Mukae, Haru; Toyoda, Kazuhiro; Taniai, Hiroaki; Okada, Kyoko; Kainuma, Mosaburo; Kajiwara, Eiji; Hayashi, Jun.
Affiliation
  • Furusyo N; Department of General Internal Medicine, Kyushu University Hospital, Fukuoka, Japan.
J Hepatol ; 57(6): 1186-92, 2012 Dec.
Article in En | MEDLINE | ID: mdl-22889955
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / Adjuvants, Pharmaceutic / Postmenopause / Hepatitis C, Chronic / Raloxifene Hydrochloride / Selective Estrogen Receptor Modulators Type of study: Clinical_trials / Observational_studies / Risk_factors_studies Limits: Aged / Female / Humans / Middle aged Language: En Journal: J Hepatol Journal subject: GASTROENTEROLOGIA Year: 2012 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / Adjuvants, Pharmaceutic / Postmenopause / Hepatitis C, Chronic / Raloxifene Hydrochloride / Selective Estrogen Receptor Modulators Type of study: Clinical_trials / Observational_studies / Risk_factors_studies Limits: Aged / Female / Humans / Middle aged Language: En Journal: J Hepatol Journal subject: GASTROENTEROLOGIA Year: 2012 Document type: Article Affiliation country: